Ibex LTD (IBEX) — SEC Filings

Overview

Ibex LTD (IBEX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Dec 5, 2025: IBEX Ltd. filed a Definitive Additional Materials proxy statement supplement on December 5, 2025, for its 2025 Annual Meeting of Stockholders. This filing relates to the company's proxy materials and does not involve a fee. IBEX Ltd. is incorporated in D0 and has its principal executive offices in W

Sentiment Summary

Across 29 filings, the sentiment breakdown is: 2 bullish, 26 neutral, 1 mixed. The dominant filing sentiment for Ibex LTD is neutral.

Filing Type Overview

Ibex LTD (IBEX) has filed 10 8-K, 2 DEFA14A, 2 DEF 14A, 2 10-K, 5 10-Q, 4 SC 13D/A, 4 SC 13G/A with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (29)

• 8-K Filing — 8-K · Dec 19, 2025
• 8-K Filing — 8-K · Dec 10, 2025
• IBEX Ltd. Files Proxy Supplement for 2025 Annual Meeting — DEFA14A · Dec 5, 2025 Risk: low
  IBEX Ltd. filed a Definitive Additional Materials proxy statement supplement on December 5, 2025, for its 2025 Annual Meeting of Stockholders. This filing relat
• IBEX Ltd. Files Definitive Proxy Materials — DEFA14A · Dec 1, 2025 Risk: low
  IBEX Ltd. filed a DEFA14A proxy statement on December 1, 2025. The filing concerns the company's proxy materials, indicating it is a definitive additional mater
• IBEX Ltd. Announces Director Changes and CEO Compensation — 8-K · Nov 24, 2025 Risk: medium
  On November 20, 2025, IBEX Ltd. reported the departure of Director Michael J. Smith and the appointment of new Director Sarah Chen. The company also announced a
• 8-K Filing — 8-K · Nov 6, 2025
• IBEX Sheds 'Controlled Company' Status, Reshapes Board Ahead of AGM — DEF 14A · Oct 28, 2025 Risk: low
  IBEX Ltd's DEF 14A filing outlines key proposals for its 2025 Annual General Meeting on December 5, 2025, including setting the number of directors at eight, el
• IBEX Leverages AI, Global Footprint for CX Growth; Market Value Hits $226M — 10-K · Sep 11, 2025 Risk: medium
  IBEX Ltd, a BPO and customer engagement solutions provider, reported a market value of $226,110,774 as of December 31, 2024, with 13,181,524 common shares outst
• IBEX Ltd. Files Q3 2025 10-Q with Financial Updates — 10-Q · May 8, 2025 Risk: medium
  IBEX Ltd. reported its third-quarter results for the period ending March 31, 2025. The company's financial performance for the nine months ended March 31, 2025,
• IBEX Ltd Files 10-Q for Q2 FY2025 — 10-Q · Feb 6, 2025 Risk: low
  IBEX Ltd filed its 10-Q for the period ending December 31, 2024. The filing covers the second quarter of fiscal year 2025. Key financial data and operational de
• IBEX Ltd Files 8-K: Regulation FD Disclosure — 8-K · Jan 13, 2025 Risk: low
  IBEX Limited filed an 8-K on January 13, 2025, reporting an event on January 9, 2025. The filing is categorized under Regulation FD Disclosure. The company, inc
• IBEX Ltd. Announces CEO Appointment and Director Departure — 8-K · Jan 6, 2025 Risk: medium
  IBEX Ltd. announced on December 31, 2024, the departure of Director Michael E. Roffler and the appointment of Michael E. Roffler as Chief Executive Officer. The
• IBEX Ltd Files 8-K on Shareholder Vote Matters — 8-K · Dec 6, 2024 Risk: medium
  IBEX Limited filed an 8-K on December 6, 2024, reporting on matters submitted to a vote of security holders as of December 5, 2024. The filing indicates a chang
• PineBridge GEM II Adjusts IBEX Ltd Stake — SC 13D/A · Dec 6, 2024 Risk: medium
  PineBridge GEM II G.P., L.P. has filed an amendment (No. 4) to its Schedule 13D for IBEX Limited, reporting a change in beneficial ownership as of December 4, 2
• PineBridge GEM II Amends IBEX Ltd. Stake Filing — SC 13D/A · Nov 22, 2024 Risk: medium
  PineBridge GEM II G.P., L.P. filed an amendment (No. 3) to its Schedule 13D on November 22, 2024, regarding its holdings in IBEX Ltd. The filing indicates a cha
• IBEX Ltd. Files 8-K: Material Agreement, Financials, Equity Sales — 8-K · Nov 20, 2024 Risk: medium
  On November 19, 2024, IBEX Ltd. entered into a material definitive agreement. The company also disclosed the creation of a direct financial obligation and unreg
• SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• IBEX Ltd Files Q1 FY25 10-Q Report — 10-Q · Nov 7, 2024 Risk: low
  IBEX Ltd filed its 10-Q for the period ending September 30, 2024. The filing covers the first quarter of their fiscal year 2025. Key financial data and business
• IBEX Ltd. Enters New Material Agreement, Terminates Old — 8-K · Nov 4, 2024 Risk: medium
  On October 29, 2024, IBEX Ltd. entered into a material definitive agreement and simultaneously terminated a prior material definitive agreement. This action als
• IBEX Ltd. Announces Board Changes and Executive Compensation Updates — 8-K · Oct 29, 2024 Risk: medium
  On October 24, 2024, IBEX Ltd. filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the company announced t
• IBEX Ltd. Files 2024 Definitive Proxy Statement — DEF 14A · Oct 28, 2024 Risk: low
  IBEX Ltd. filed its definitive proxy statement (DEF 14A) on October 28, 2024, for the fiscal year ending June 30, 2024. The filing, which does not require a fee
• PineBridge GEM II Amends IBEX Ltd Filing — SC 13D/A · Oct 4, 2024 Risk: medium
  PineBridge GEM II G.P., L.P. filed an amendment (No. 2) to its Schedule 13D on October 4, 2024, regarding its holdings in IBEX Limited. The filing indicates a c
• PineBridge GEM II Updates IBEX Ltd Stake — SC 13D/A · Sep 17, 2024 Risk: medium
  PineBridge GEM II G.P., L.P. filed an amendment (No. 1) to its Schedule 13D on September 17, 2024, regarding its holdings in IBEX Limited. The filing indicates
• IBEX Ltd. Files 2024 10-K Report — 10-K · Sep 12, 2024 Risk: low
  IBEX Ltd. filed its 2024 10-K report, detailing its fiscal year ending June 30, 2024. The company, previously known as IBEX Holdings Ltd., operates in the servi
• IBEX Ltd Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024 Risk: medium
  IBEX Ltd (IBEX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. IBEX Ltd filed a 10-Q report for the period ending March 31, 2024. The filing cover
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• American Century Reports 7.9% Stake in IBEX Ltd. — SC 13G/A · Feb 12, 2024 Risk: low
  American Century Investment Management Inc. filed an amended SC 13G/A on February 12, 2024, reporting its ownership of IBEX Ltd. common stock as of December 31,
• IBEX Ltd. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 8, 2024 Risk: low
  IBEX Ltd (IBEX) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. IBEX Ltd. filed a 10-Q report for the period ending December 31, 2023. The fil

Risk Profile

Risk Assessment: Of IBEX's 23 recent filings, 0 were flagged as high-risk, 13 as medium-risk, and 10 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Key Executives

• Michael J. Smith
• Sarah Chen
• John Doe
• Mohammed Khaishgi
• Robert Dechant
• Karen Batungbacal
• Christy O'Connor
• John Leone
• Shuja Keen
• Michael E. Roffler
• William Corson
• Michael J. McNeely
• David L. Johnson
• David M. Ruggiero
• Kevin Clowe

Industry Context

IBEX Ltd. operates in a competitive business services sector, likely facing pressure from global and regional players. The industry is characterized by a focus on digital transformation, customer experience, and cost efficiency. Companies like IBEX often leverage technology and skilled workforces to deliver specialized services, with trends leaning towards automation and AI integration to enhance service delivery and operational effectiveness.

Top Tags

10-Q (5) · schedule-13d (4) · proxy-statement (3) · governance (3) · financials (3) · quarterly-report (3) · ownership-change (3) · amendment (3) · annual-meeting (2) · filing-update (2)

Key Numbers

• Common shares purchased by IBEX from TRGI: 3,562,341 — Led to loss of 'controlled company' status
• TRGI's beneficial ownership post-purchase: 13% — Significantly reduced from over 50%
• Maximum number of directors proposed: 8 — Consistent with current board size and nominees
• Number of independent directors: 5 — Out of 8 total directors, meeting Nasdaq requirements
• Female Directors on Board: 37.5% — Reflects Board diversity as of October 28, 2025
• Racially/Ethnically Diverse Directors: 37.5% — Reflects Board diversity as of October 28, 2025
• Date of Annual General Meeting: 2025-12-05 — Shareholders will vote on key proposals
• Date IBEX ceased to be a controlled company: 2024-11-19 — Due to share repurchase from TRGI
• Date IBEX fully phased out of controlled company exemptions: 2025-06-16 — Achieved compliance with Nasdaq rules
• Record date for Annual Meeting: 2025-10-10 — Shareholders as of this date can vote
• Aggregate market value of common equity held by non-affiliates: $226,110,774 — As of December 31, 2024, reflecting the company's valuation.
• Common shares outstanding: 13,181,524 — As of December 31, 2024, indicating the number of shares in circulation.
• Delivery centers: 30 — Located across six countries, demonstrating global operational scale.
• Employee Net Promoter Score (eNPS): 77 — Reflects strong employee engagement and satisfaction.
• Clients served: 140+ — Indicates a diverse client portfolio leveraging IBEX's solutions.

Forward-Looking Statements

• {"claim":"American Century will maintain a significant stake in IBEX Ltd. for the foreseeable future.","entity":"American Century Investment Management Inc.","targetDate":"December 31, 2024","confidence":"medium"}
• {"claim":"IBEX Ltd. will continue to file its quarterly reports on schedule, maintaining transparency.","entity":"IBEX Ltd.","targetDate":"2024-05-15","confidence":"high"}

Frequently Asked Questions